What is Etilaam 1 Mg ?
Etilaam 1 mg Tablet (Etizolam 1 Mg) is an effective anti-anxiety medicine that is similar to benzodiazepine class of medicines. It is used for the management of anxiety and short-term treatment of insomnia (sleeplessness).
It is not to be used for pregnant and lactating women, for those with impaired kidney and liver functions, lung problems, and glaucoma. There may be enhanced sedation when had with medicines like beta blockers, anti bacterials, anti fungals and antipsychotics.
It comes in the form of a tablet, to be taken with food. The recommended dosage for an adult is 3mg a day. Never take a double dose of Etilaam 1Mg Tablet, it is better that you skip it till the next time you take it. Remember to ask the doctor any queries that you may have about the medicine and the course of the treatment.
The most common side effects of Etilaam 1Mg Tablet are drowsiness, sedation, muscle weakness and lack of cordination. More serious effects that urgently require medical help are fainting, slurred speech, changes in libido and tremors.
Given below are some of the side effects of Etilaam 1 Mg
Major & minor side effects for Etilaam 1 mg Tablet
- Muscle weakness
- Slurred speech
- Change in libido
- Uncontrolled shaking of arms or legs
- Visual disturbances
- Urinary retention/incontinence
- Stomach discomfort and pain
- Excessive salivation
- Memory problems
- If you are taking Etilaam 1 mg Tablet for the treatment of insomnia and anxiety, it should not be used more than 4 weeks.
- It may become less effective over the time.
- It causes sleepiness or drowsiness. If this happens to you, do not drive or use machinery.
Avoid consuming alcohol when taking the Etilaam 1 mg Tablet, as it may cause excessive sleepiness or drowsiness.
Inform your doctor if you are pregnant or planning to conceive or breastfeeding.
- Inform your doctor if you have ever been diagnosed with kidney or liver problems.
The addiction / habit-forming potential of Etilaam 1 mg Tablet is very high.
The metabolism of Etizolam can be decreased when combined with (R)-warfarin.
The metabolism of (S)-Warfarin can be decreased when combined with Etilaam.
The therapeutic efficacy of Etizolam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.
The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Etizolam.
The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Etizolam.
The metabolism of 4-hydroxycoumarin can be decreased when combined with Etizolam.
The risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Etizolam.
The metabolism of Etizolam can be decreased when combined with 5-androstenedione.
The metabolism of Etizolam can be decreased when combined with 6-Deoxyerythronolide B.
The therapeutic efficacy of Etizolam can be decreased when used in combination with 6-O-benzylguanine.